FDA: Prolia Use in Dialysis Patients May Cause Severe Hypocalcemia
According to a long-term safety study and a separate FDA internal study, Prolia had an increased risk of hypocalcemia in patients with advanced kidney disease on dialysis.
Diagnosis & Disease Information
Alendronate Protects Against Bone Loss in Kidney Transplant Recipients
Decrease in bone mass is common in the first 6 to 12 months after kidney transplantation.
DXA Screening Rate Low Among Older Men Initiating Prostate Cancer ADT
Study confirms the care gap in bone health management and fracture prevention among older men with prostate cancer receiving androgen deprivation therapy.
Alendronate May Reduce Risk for Type 2 Diabetes
Adjusted odds ratio for type 2 diabetes further reduced for those with more than 8 years of alendronate use
Denosumab Improves Bone Disease in Kidney Transplant Recipients
The medication inhibits bone resorption but is associated with prolonged elevation in PTH levels that require treatment.
Bone Turnover Lower Among Men With Type 2 Diabetes Mellitus, A1c Greater Than 7%
Study authors identified whether the hemoglobin A1c threshold level where reduction in bone turnover begins.
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...